0001354457-23-000999.txt : 20231227
0001354457-23-000999.hdr.sgml : 20231227
20231227090224
ACCESSION NUMBER: 0001354457-23-000999
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20231227
DATE AS OF CHANGE: 20231227
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-224278
BUSINESS ADDRESS:
STREET 1: 124 WASHINGTON STREET, SUITE 101
CITY: FOXBORO
STATE: MA
ZIP: 02035
BUSINESS PHONE: 617-577-0300
MAIL ADDRESS:
STREET 1: 124 WASHINGTON STREET, SUITE 101
CITY: FOXBORO
STATE: MA
ZIP: 02035
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
ORGANIZATION NAME:
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001694665
Evelo Biosciences, Inc.
333-224278
620 Memorial Drive, Suite 200
Cambridge
MA
MASSACHUSETTS
02139
6175770300
Common Stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-12-27
EX-99.25
2
evlodelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, December 27, 2023,
Evelo Biosciences, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Evelo Biosciences, Inc., effective
at the opening of the trading session on January 8, 2024.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101.
The Company was notified of the Staff determination on December 1, 2023.
The Company did not appeal the Staff determination to the Hearings Panel.
The Company securities were suspended on December 12, 2023. The Staff
determination to delist the Company securities became final on
December 12, 2023.